New treatments for restoring impaired epidermal barrier permeability: Skin barrier repair creams

Clinics in Dermatology

Volumn 30, Issue 3, 2012, Pages 345-348

  Draelos, Zoe Diana ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLANTOIN; ATOPICLAIR; BIAFINE; BISABOLOL; CERAMIDE; COSMETIC; CYCLOMETHICONE; DIMETICONE; ELETONE; EPICERAM; FLUTICASONE; GLYCEROL; GLYCYRRHETINIC ACID; GLYCYRRHIZA EXTRACT; HERBACEOUS AGENT; HYALURONIC ACID; HYLATOPIC; MIMYX; NEOSALUS; PALMIDROL; PARAFFIN; PETROLATUM; SILICONE DERIVATIVE; TETRIX; UNCLASSIFIED DRUG; VITIS VINIFERA EXTRACT;

ANTIINFLAMMATORY ACTIVITY; ATOPIC DERMATITIS; BODY TEMPERATURE; BURN; CLINICAL TRIAL (TOPIC); CONTACT DERMATITIS; CREAM; DRUG APPROVAL; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG SAFETY; DRY SKIN; ELECTROLYTE BALANCE; EPIDERMAL BARRIER PERMEABILITY IMPAIRMENT; ERYTHEMA; FOOD AND DRUG ADMINISTRATION; HUMAN; HYDROPHILICITY; IMMUNE RESPONSE; LICHENOID ERUPTION; NOTE; OUTCOME ASSESSMENT; PERMEABILITY BARRIER; PRESCRIPTION; PRIORITY JOURNAL; PRURITUS; RADIATION DERMATITIS; SKIN ALLERGY; SKIN DEFECT; SKIN FUNCTION; SKIN IRRITATION; SKIN PROTECTION; SKIN SENSATION; SKIN ULCER; SKIN WATER LOSS; VISUAL ANALOG SCALE; WOUND;

ADMINISTRATION, TOPICAL; COSMETICS; EMOLLIENTS; EPIDERMIS; HUMANS; PERMEABILITY; SKIN ABSORPTION; SKIN DISEASES; WATER LOSS, INSENSIBLE; WOUND HEALING;

EID: 84859786008     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2011.08.018     Document Type: Note

References (19)

1. Novotný J., Hrabálek A., Vávrová K. Synthesis and structure-activity relationships of skin ceramides. Curr Med Chem 2010, 17:2301-2324.
2. Garidel P., Fölting B., Schaller I., Kerth A. The microstructure of the stratum corneum lipid barrier: mid-infrared spectroscopic studies of hydrated ceramide: palmitic acid: cholesterol model systems. Biophys Chem 2010, 150:144-156.
3. Madaan A. Epiceram for the treatment of atopic dermatitis. Drugs Today (Barc) 2008, 44:751-755.
4. Sugarman J.L., Parish L.C. Efficacy of a lipid-based barrier repair formulation in moderate-to-severe pediatric atopic dermatitis. J Drugs Dermatol 2009, 81:106-111.
5. Ivanov C., Michova M., Russeva R., Batashki I. Clinical application of bionect (hyaluronic acid sodium salt) in wound care by cesarean section and episiotomy. Akush Ginekol (Sofiia) 2007, 46(suppl 4):20-26.
6. Amado A., Taylor J.S., Murray D.A., Reynolds J.S. Contact dermatitis to pentylene glycol in a prescription cream for atopic dermatitis: a case report. Arch Dermatol 2008, 144:810-812.
7. Abramovits W., Perlmutter A., Mimy X. Cream. Skinmed 2006, 52:9-30.
8. Cosmetic Ingredient Review Expert Panel Final report on the safety assessment of glycyrrhetinic acid, potassium glycyrrhetinate, disodium succinoyl glycyrrhetinate, glyceryl glycyrrhetinate, glycyrrhetinyl stearate, stearyl glycyrrhetinate, glycyrrhizic acid, ammonium glycyrrhizate, dipotassium glycyrrhizate, disodium glycyrrhizate, trisodium glycyrrhizate, methyl glycyrrhizate, and potassium glycyrrhizinate. Int J Toxicol 2007, 267:9-112.
9. Eberlein B., Eicke C., Reinhardt H.W., Ring J. Adjuvant treatment of atopic eczema: Assessment of an Emollient Containing N-Palmitoylethanolamine (ATOPA Study). J Eur Acad Dermatol Venereol 2008, 227:3-82.
10. Veraldi S., De Micheli P., Schianchi R., Lunardon L. Treatment of pruritus in mild-to-moderate atopic dermatitis with a topical non-steroidal agent. J Drugs Dermatol 2009, 85:37-39.
11. Boguniewicz M., Zeichner J.A., Eichenfield L.F., et al. MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants and children: a multicenter, randomized, vehicle-controlled study. J Pediatr 2008, 1528:54-59.
12. Buraczewska I., Berne B., Lindberg M., Törmä H., Loden M. Changes in skin barrier function following long-term treatment with moisturizers, a random controlled trial. Br J Dermatol 2007, 1564:92-98.
13. Becker L.C., Bergfeld W.F., Belsito D.V., et al. Final report of the safety assessment of allantoin and its related complexes. Int J Toxicol 2010, 298:4S-97S.
14. Morrison D.S. Petrolatum: a useful classic. Cosmet Toilet 1996, 111:59-69.
15. Ruiz M.A., Hernandez A., Llacer J.M., Gallardo V. Silicone chemistry. Cosmet Toilet 1998, 113:57-62.
16. Slade H.B., Fowler J., Draelos Z.D., Reece B.T., Cargill D.I. Clinical efficacy evaluation of a novel barrier protection cream. Cutis 2008, 822:1-8.
17. Slade H.B., Fowler J., Reece B.T., Cargill D.I. Clinical safety evaluation of a novel barrier protection cream. Cutis 2008, 821:6-20.
18. Coulomb B., Friteau L., Dubertret L. Biafine applied on human epidermal wounds is chemotactic for macrophages and increases the IL-1/IL-6 ratio. Skin Pharmacol 1997, 102:81-87.
19. Cohen J.L., Jorizzo J.L., Kircik L.H. Use of a topical emulsion for wound healing. J Support Oncol 2007, 51:1-9.